Latest Director Remuneration News

BOA Resources Ltd reported a steady cash position of AUD 1.067 million at the end of Q1 2025, underpinning an estimated four quarters of operational funding. The quarterly cash flow report highlights disciplined spending amid ongoing exploration activities.

Dreadnought Resources has bolstered its exploration and development efforts with over A$13 million in fresh funding, advancing its high-grade Mangaroon gold project and critical minerals assets in Western Australia.

Peel Mining Limited has reported a significant upgrade to its Wagga Tank Mineral Resource Estimate, enhancing the South Cobar Project’s global resource base and advancing its pre-feasibility study with promising cost and timeline benefits.

FINEOS Corporation Holdings PLC reported a robust first quarter for FY25, with cash balances soaring to €35.4 million and customer receipts up 40% year-on-year, underpinned by successful platform deployments and a healthy sales pipeline in North America.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

European Metals Holdings has made significant strides in developing its Cinovec Lithium Project, announcing a strategic relocation of its processing plant and ongoing enhancements to production capacity and cost efficiency. The Definitive Feasibility Study is on track for mid-2025 completion, promising a clearer outlook on the project's economic potential.

Toro Energy reports steady progress in its Wiluna Uranium Project with updated resource estimates and ongoing native title consultations, positioning itself to capitalize on improving uranium market conditions.

Somerset Minerals Ltd has taken a significant step forward by entering a conditional agreement to acquire the high-grade Coppermine Project in Nunavut, Canada, while completing the sale of its Valle del Tigre II mineral concession in Ecuador. Preparations are underway for a maiden exploration campaign at Coppermine, targeting substantial copper-silver mineralisation.

Bounty Oil and Gas NL reports steady cash reserves and rising oil production in Queensland, while facing regulatory setbacks offshore. The company’s strategic developments and entitlement offer position it for growth in 2025.

Mustera Property Group progresses design and marketing for its McCabe Street development while maintaining sales momentum at Forbes Residences, alongside a notable executive remuneration update.

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.